Dynamic network reconfiguration in hepatitis B cirrhosis secondary to mild hepatic encephalopathy: a multilayer network analysis
Quantitative Imaging in Medicine and Surgery · 2026-02 · 16 (2) · 163-163
DOI: 10.21037/qims-24-2442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Quantitative Imaging in Medicine and Surgery, 2026-02. Verfasst von Chao Ju und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Static functional networks of the brain are disrupted in minimal hepatic encephalopathy (MHE), but their dynamic alterations are unknown. This observational study utilized multilayer network analysis to investigate dynamic network characteristics in hepatitis B cirrhosis (HBC) with or without MHE and assess their association with neurocognitive function (registry: https://ctms.xyeyy.com/iit/project/index; trial registration number: LYF20240134; date: 2024-07-31).
Methods
A total of 33 HBC patients [15 non-MHE (NMHE; HBC patients without MHE) and 18 MHE individuals], as well as 36 matched healthy controls (HCs), underwent neurocognitive assessments, resting-state functional magnetic resonance imaging (rs-fMRI), and clinical examinations. Dynamic network variations were quantified using network switching rates, and their relationships with clinical and neurocognitive parameters were evaluated.
Results
Both HBC patients with and without MHE status exhibited a range of altered network switching rates compared to HCs. Specifically, differences were observed in subnetworks including somatomotor network (SMN), dorsal attention network (DAN), ventral attention network (VAN), frontoparietal network (FPN), and subcortical network (SUB), as well as in nodal regions such as the right precentral gyrus (rPrG), left fusiform gyrus (lFuG), left inferior parietal lobule (lIPL), and right hippocampus (rHipp). Furthermore, altered global level and lFuG switching rates positively correlated with Psychometric Hepatic Encephalopathy Score (PHES) (r=0.341, 0.339; P=0.004, 0.004, respectively, Bonferroni corrected).
Conclusions
This study firstly revealed that HBC patients exhibited imbalanced functional dynamics in subnetworks and nodes, suggesting a potential mechanism underlying cerebral dysfunction in MHE.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Infectious Diseases, The Second Xiangya Hospital of Central South University, Changsha, China.
- Furong Laboratory, Changsha, China.
- Clinical Research Center for Viral Hepatitis in Hunan Province, Changsha, China.
- Department of Radiology, Quality Control Center in Hunan Province, Changsha, China.
- Clinical Research Center for Medical Imaging in Hunan Province, Changsha, China.
Zitieren
APA
Ju, C., Yang, L., Dai, Z., Wang, Y., Li, C., Zhao, W., Jiang, Y., & Liu, J. (2026). Dynamic network reconfiguration in hepatitis B cirrhosis secondary to mild hepatic encephalopathy: a multilayer network analysis. Quantitative Imaging in Medicine and Surgery, 16(2), 163-163. https://doi.org/10.21037/qims-24-2442
Vancouver
Ju C, Yang L, Dai Z, Wang Y, Li C, Zhao W, et al. Dynamic network reconfiguration in hepatitis B cirrhosis secondary to mild hepatic encephalopathy: a multilayer network analysis. Quantitative Imaging in Medicine and Surgery. 2026;16(2):163-163. doi:10.21037/qims-24-2442
BibTeX
@article{Ju2026,
author = {Ju, Chao and Yang, Longtao and Dai, Zhongshang and Wang, Yisong and Li, Chang and Zhao, Wei and Jiang, Yongfang and Liu, Jun},
title = {Dynamic network reconfiguration in hepatitis B cirrhosis secondary to mild hepatic encephalopathy: a multilayer network analysis},
journal = {Quantitative Imaging in Medicine and Surgery},
year = {2026},
volume = {16},
number = {2},
pages = {163--163},
doi = {10.21037/qims-24-2442}
}
EUVIMED